Literature DB >> 19765363

Clinical significance of inflammatory markers.

Bincy P Abraham1, Selvi Thirumurthi.   

Abstract

Inflammatory markers play a key role in the evaluation of patients with gastrointestinal symptoms. For patients presenting with nonspecific symptoms of abdominal pain and diarrhea, distinguishing inflammatory bowel disease from other disorders can be difficult, and invasive diagnostic procedures may be required. Inflammatory markers can be useful to differentiate patients who may require further workup from those who do not. Several serum, fecal, and other markers are reviewed for their use in clinical practice. Although no single ideal marker exists, a few show promise in diagnosing inflammatory disease, monitoring disease activity, and predicting relapse.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19765363     DOI: 10.1007/s11894-009-0055-x

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  58 in total

1.  Assessment of the neutrophil dominating protein calprotectin in feces. A methodologic study.

Authors:  A G Røseth; M K Fagerhol; E Aadland; H Schjønsby
Journal:  Scand J Gastroenterol       Date:  1992-09       Impact factor: 2.423

2.  Evaluation of intestinal clearance and faecal excretion of alpha 1-antiproteinase and immunoglobulins during Crohn's disease and ulcerative colitis.

Authors:  N Kapel; D Meillet; L Favennec; D Magne; D Raichvarg; J G Gobert
Journal:  Eur J Clin Chem Clin Biochem       Date:  1992-04

3.  Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn's disease.

Authors:  Iris Dotan; Sigal Fishman; Yaara Dgani; Mikael Schwartz; Amir Karban; Aaron Lerner; Oori Weishauss; Larissa Spector; Avi Shtevi; Rom T Altstock; Nir Dotan; Zamir Halpern
Journal:  Gastroenterology       Date:  2006-08       Impact factor: 22.682

4.  A comparative study of goblet cell and pancreatic exocine autoantibodies combined with ASCA and pANCA in Chinese and Caucasian patients with IBD.

Authors:  Ian Craig Lawrance; Anne Hall; Rupert Leong; Callum Pearce; Kevin Murray
Journal:  Inflamm Bowel Dis       Date:  2005-10       Impact factor: 5.325

5.  Alpha 1-antitrypsin, a reliable endogenous marker for intestinal protein loss and its application in patients with Crohn's disease.

Authors:  U Karbach; K Ewe; H Bodenstein
Journal:  Gut       Date:  1983-08       Impact factor: 23.059

Review 6.  Serologic markers in inflammatory bowel disease.

Authors:  Xavier Bossuyt
Journal:  Clin Chem       Date:  2005-12-08       Impact factor: 8.327

7.  Serum immune responses predict rapid disease progression among children with Crohn's disease: immune responses predict disease progression.

Authors:  Marla C Dubinsky; Ying-Chao Lin; Debra Dutridge; Yoana Picornell; Carol J Landers; Sharmayne Farrior; Iwona Wrobel; Antonio Quiros; Eric A Vasiliauskas; Bruce Grill; David Israel; Ron Bahar; Dennis Christie; Ghassan Wahbeh; Gary Silber; Saied Dallazadeh; Praful Shah; Danny Thomas; Drew Kelts; Robert M Hershberg; Charles O Elson; Stephan R Targan; Kent D Taylor; Jerome I Rotter; Huiying Yang
Journal:  Am J Gastroenterol       Date:  2006-02       Impact factor: 10.864

Review 8.  C-reactive protein as a marker for inflammatory bowel disease.

Authors:  Séverine Vermeire; Gert Van Assche; Paul Rutgeerts
Journal:  Inflamm Bowel Dis       Date:  2004-09       Impact factor: 5.325

9.  Update on Anti-Saccharomyces cerevisiae antibodies, anti-nuclear associated anti-neutrophil antibodies and antibodies to exocrine pancreas detected by indirect immunofluorescence as biomarkers in chronic inflammatory bowel diseases: results of a multicenter study.

Authors:  S Desplat-Jégo; C Johanet; A Escande; J Goetz; N Fabien; N Olsson; E Ballot; J Sarles; J J Baudon; J C Grimaud; M Veyrac; P Chamouard; R L Humbel
Journal:  World J Gastroenterol       Date:  2007-04-28       Impact factor: 5.742

10.  Pancreatic autoantibodies are associated with reactivity to microbial antibodies, penetrating disease behavior, perianal disease, and extraintestinal manifestations, but not with NOD2/CARD15 or TLR4 genotype in a Hungarian IBD cohort.

Authors:  Peter Laszlo Lakatos; Istvan Altorjay; Tamas Szamosi; Karoly Palatka; Zsuzsanna Vitalis; Judit Tumpek; Sandor Sipka; Miklos Udvardy; Tamas Dinya; Laszlo Lakatos; Agota Kovacs; Tamas Molnar; Zsolt Tulassay; Pal Miheller; Zsolt Barta; Winfried Stocker; Janos Papp; Gabor Veres; Maria Papp
Journal:  Inflamm Bowel Dis       Date:  2009-03       Impact factor: 5.325

View more
  4 in total

1.  The mantra of mucosal healing.

Authors:  Joseph H Sellin
Journal:  Curr Gastroenterol Rep       Date:  2011-10

2.  Dysbiosis of salivary microbiota in inflammatory bowel disease and its association with oral immunological biomarkers.

Authors:  Heba S Said; Wataru Suda; Shigeki Nakagome; Hiroshi Chinen; Kenshiro Oshima; Sangwan Kim; Ryosuke Kimura; Atsushi Iraha; Hajime Ishida; Jiro Fujita; Shuhei Mano; Hidetoshi Morita; Taeko Dohi; Hiroki Oota; Masahira Hattori
Journal:  DNA Res       Date:  2013-09-07       Impact factor: 4.458

3.  Prognostic value of assessment of stool and serum IL-1β, IL-1ra and IL-6 concentrations in children with active and inactive ulcerative colitis.

Authors:  Andrzej Wędrychowicz; Przemysław Tomasik; Andrzej Zając; Krzysztof Fyderek
Journal:  Arch Med Sci       Date:  2017-06-30       Impact factor: 3.318

4.  Salivary Biomarkers for Diagnosis of Inflammatory Bowel Diseases: A Systematic Review.

Authors:  Kacper Nijakowski; Anna Surdacka
Journal:  Int J Mol Sci       Date:  2020-10-10       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.